Citation: C. Merry, Editorial comment on Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients, AIDS, 15(8), 2001, pp. 1057-1058
Authors:
Back, DJ
Khoo, SH
Gibbons, SE
Barry, MG
Merry, C
Citation: Dj. Back et al., Therapeutic drug monitoring of antiretrovirals in human immunodeficiency virus infection, THER DRUG M, 22(1), 2000, pp. 122-126
Authors:
Barry, M
Mulcahy, F
Merry, C
Gibbons, S
Back, D
Citation: M. Barry et al., Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection, CLIN PHARMA, 36(4), 1999, pp. 289-304
Authors:
Kyne, L
Merry, C
O'Connell, B
Kelly, A
Keane, C
O'Neill, D
Citation: L. Kyne et al., Factors associated with prolonged symptoms and severe disease due to Clostridium difficile, AGE AGEING, 28(2), 1999, pp. 107-113
Citation: S. Clarke et al., Pneumococcal pneumonia associated with perianal herpes simplex virus type 2 in a HIV seropositive patient, J EUR A D V, 11(3), 1998, pp. 257-258